Decibel Therapeutics Inc – Material Contracts Watch

EX-10.3

from 10-Q 2 pages Second Amendment to License Agreement No. A19433

12/34/56

EX-10.2

from 10-Q 31 pages Amended and Restated Exclusive License Agreement

12/34/56

EX-10

from 10-K 5 pages Amendment No. 2 to the License and Collaboration Agreement

12/34/56

EX-10.2

from 10-Q 6 pages Decibel Therapeutics, Inc. 2021 Employee Stock Purchase Plan

12/34/56

EX-10.1

from 10-Q 9 pages Via Electronic Mail September 9, 2022 • as of the Separation Date, All Salary Payments From the Company (Except for Your Final Paycheck) Will Cease and Any Benefits You Had as of the Separation Date Under Company-Provided Benefit Plans, Programs, or Practices Will Terminate, Except as Required by Federal or State Law

12/34/56

EX-10.2

from 10-Q 2 pages First Amendment to License Agreement No. A19433

12/34/56

EX-10.1

from 10-Q 5 pages Second Amendment to the Exclusive License Agreement Dated 8/26/2019

12/34/56

EX-10.1

from 10-Q 9 pages Form of Severance and Change in Control Benefits Agreement

12/34/56

EX-10.10

from S-1/A 7 pages Decibel Therapeutics, Inc. 2021 Employee Stock Purchase Plan

12/34/56

EX-10.6

from S-1/A 15 pages Decibel Therapeutics, Inc. 2021 Stock Incentive Plan

12/34/56

EX-10.2

from S-1/A 16 pages 2015 Stock Incentive Plan of Decibel Therapeutics, Inc. I

12/34/56

EX-10.27

from S-1/A 3 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company, if Publicly Disclosed. Double Asterisks Denote Omissions. First Amendment to the License Agreement Dated 8/26/2019 Between the Curators of the University of Missouri and Decibel Therapeutics, Inc

12/34/56

EX-10.26

from S-1 5 pages Consulting Agreement

12/34/56

EX-10.25

from S-1 20 pages Sublease Agreement

12/34/56

EX-10.24

from S-1 7 pages Name Address Re: Decibel Therapeutics, Inc. Change in Control Agreement Dear

12/34/56

EX-10.23

from S-1 2 pages October 12, 20 I 6 Re: Offer of Employment Dear Ron: Decibel Therapeutics, Inc. (The “Company”) Is Pleased to Confirm Its Offer to Employ You as Senior Director, Finance Reporting to Steve Holtzman, President & CEO. Your Effective Date of Hire as an Employee (The “Start Date”) Shall Be Monday, November 28, 2016 Unless Another Date Is Agreed Upon by You and the Company. Your Normal Place of Work Will Be at the Company’s Offices in Cambridge, Ma

12/34/56

EX-10.22

from S-1 2 pages December 19, 2017 Re: Offer of Employment Dear Anna: Decibel Therapeutics, Inc. (The “Company”) Is Pleased to Confirm Its Offer to Employ You as Vice President, People, Community. and Culture Reporting to Steve Holtzman. Chief Executive Officer. Your Effective Date of Hire as an Employee (The “Start Date”) Shall Be No Later Than January 2, 2018 Unless Another Date Is Agreed Upon by You and the Company. Your Normal Place of Work Will Be at the Company’s Offices in Boston, Ma

12/34/56

EX-10.21

from S-1 3 pages September 9, 2020 Re: Offer of Employment Dear Lis: Decibel Therapeutics, Inc. (The “Company”) Is Pleased to Confirm Its Offer to Employ You as Chief Financial Officer, Reporting to Laurence Reid, Chief Executive Officer. 1. Date of Hire. Your Effective Date of Hire as an Employee (The “Start Date”) Shall Be No Later Than September 14, 2020 Unless Another Date Is Agreed Upon by You and the Company. You Will Be a Remote Employee Based in New York

12/34/56

EX-10.20

from S-1 2 pages August 11, 2016 Re: Offer of Employment Dear John: Decibel Therapeutics, Inc. (The “Company”) Is Pleased to Confirm Its Offer to Employ You as Senior Vice President, Pharmaceutical Development Reporting to Steve Holtzman, President & CEO. Your Effective Date of Hire as an Employee (The “Start Date”) Shall Be No Later Than Tuesday, September 6, 2016 Unless Another Date Is Agreed Upon by You and the Company. Your Normal Place of Work Will Be at the Company’s Offices in Cambridge, Ma

12/34/56

EX-10.19

from S-1 5 pages June 17, 2016 Re: Offer of Employment Dear Steve

12/34/56